Receptor Status and Associated Clinico-Histopathological Characteristics among Women with Breast Cancer in a Ugandan Tertiary Hospital

Receptor Status and Associated Clinico-Histopathological Characteristics among Women with Breast Cancer in a Ugandan Tertiary Hospital

Show other versions (1)

Background: The breast cancer landscape in Uganda is characterized by late disease and poor outcomes. Even though receptor status is an important prognostic factor, it is not routinely conducted in the country. This study was set to describe the oestrogen receptors (ER) status and associated cli...

Full description

Bibliographic Details
Main Authors:	Babalanda JNP, Galukande M, Jombwe JG, Fualal JO
Format:	Article
Language:	English
Published:	Surgical Society of Kenya 2018-10-01
Series:	The Annals of African Surgery
Subjects:	breast cancer advanced stage hormonal receptor status triple negative breast cancer
Online Access:	https://www.annalsofafricansurgery.com/receptor-status-and-associated-clin

Similar Items

Receptor Status and Associated Clinico-Histopathological Characteristics among Women with Breast Cancer in a Ugandan Tertiary Hospital
by: Babalanda JNP, et al.
Published: (2014-07-01)

Male breast cancer: A retrospective review of clinical profile from a tertiary cancer care center of India
by: Dharma Ram, et al.
Published: (2017-01-01)

Molecular breast cancer subtypes prevalence in an indigenous Sub Saharan African population
by: Moses Galukande, et al.
Published: (2014-04-01)

Histopathological Variants and Molecular Subtypes of Carcinoma Breast in a Tertiary Care Centre, Kerala, India: A Cross-sectional Study
by: Anjali Raju, et al.
Published: (2023-07-01)

Clinical and histopathological characteristics associated with patients with triple-negative Breast cancer at a national reference hospital, 2012 - 2018
by: Giuliana Mandujano-Guizado, et al.
Published: (2019-06-01)

Evaluation of Androgen Receptor in Various Molecular Subtypes of Carcinoma Breast and its Relationship with Clinicopathological Parameters: A Retrospective Study
by: Vaishali A Walke, et al.
Published: (2021-01-01)

Combined use of apatinib mesylate and vinorelbine versus vinorelbine alone in recurrent or metastatic triple-negative breast cancer: study protocol for a randomized controlled clinical trial
by: Shuo Wu, et al.
Published: (2020-05-01)

Does triple negative breast cancer subtype carry poorer prognosis as compared to non-triple negative breast cancer lesion - A study from a tertiary hospital
by: Srijan Basu, et al.
Published: (2023-11-01)

A clinicopathologic study of triple negative breast cancer
by: Vandana L Gaopande, et al.
Published: (2015-01-01)

Editorial: Early diagnoses and treatments of uncommon breast cancers
by: Ernestina Marianna De Francesco, et al.
Published: (2022-10-01)

Retrospective Observational Study to Determine the Epidemiology and Treatment Patterns of Patients with Triple-Negative Breast Cancer
by: Magdalena Rosińska, et al.
Published: (2024-03-01)

Metastatic Breast Cancer and Hormonal Receptor Status among a Group of Women in Sub Saharan Africa
by: Nabawanuka A, et al.
Published: (2018-10-01)

Management of triple negative breast cancer in a centenarian
by: Andrew Donaldson, et al.
Published: (2022-09-01)

Profile and Outcome of Triple Negative Breast Cancer at a Tertiary Care University Hospital in Nepal
by: Suman Khanal, et al.
Published: (2020-06-01)

Effects of Cortactin Expression on Prognosis in Patients with Breast Cancer
by: Hwangkyu Son, et al.
Published: (2023-09-01)

Thymoquinone Alterations of the Apoptotic Gene Expressions and Cell Cycle Arrest in Genetically Distinct Triple-Negative Breast Cancer Cells
by: Getinet M. Adinew, et al.
Published: (2022-05-01)

Characteristics of Patients with Estrogen Receptor (ER)-Negative, Progesterone Receptor (PR)-Negative, and HER2-Negative Invasive Breast Cancer in Dr. Hasan Sadikin General Hospital, Bandung, Indonesia from 2010 to 2011
by: Nadytia Kusumadjayanti, et al.
Published: (2015-09-01)

Long-term complete response with third-line PARP inhibitor after immunotherapy in a patient with triple-negative breast cancer: a case report
by: Roberta Caputo, et al.
Published: (2023-08-01)

Giant Fungated Locally Advanced Breast Carcinoma Responded to Hypofractionated Radiotherapy Combined with Apatinib: A Case Report and Literature Review
by: Liu H, et al.
Published: (2021-01-01)

Real-World Data from a Refractory Triple-Negative Breast Cancer Cohort Selected Using a Clinical Data Warehouse Approach
by: Hana Kim, et al.
Published: (2021-11-01)

A retrospective study of clinico-pathological spectrum of carcinoma breast in a West Delhi, India
by: Jitendra Singh Nigam, et al.
Published: (2014-01-01)

Secretory carcinoma of the breast: A case report and literature review
by: I-Kai Wu, et al.
Published: (2021-01-01)

Neoadjuvant Treatment of Stage IIB/III Triple Negative Breast Cancer with Cyclophosphamide, Doxorubicin, and Cisplatin (CAP Regimen): A Single Arm, Single Center Phase II Study (GBECAM 2008/02)
by: Arlindo R. Ferreira, et al.
Published: (2018-01-01)

Comparison of Clinicopathological Characteristics Between Primary and Contralateral Cancers in BRCA1/2 Carriers with Metachronous Bilateral Breast Cancers
by: DING Xinyun, et al.
Published: (2023-07-01)

A case report and literature review on a rare subtype of triple-negative breast cancer in children
by: Lexiang Shi, et al.
Published: (2023-09-01)

The Role and Therapeutic Targeting of CCR5 in Breast Cancer
by: Rasha Hamid, et al.
Published: (2023-09-01)

Metaplastic Carcinoma of the Breast: Case Series of a Single Institute and Review of the Literature
by: Alkistis Papatheodoridi, et al.
Published: (2023-05-01)

Triple-negative breast cancer arising in a fibroadenoma in BRCA 1 mutated patient
by: Nicole Brunetti, et al.
Published: (2023-01-01)

Triple Negative Breast Cancer: A Review of Present and Future Diagnostic Modalities
by: Sylvia Annabel Dass, et al.
Published: (2021-01-01)

Metastatic Triple Negative Breast Cancer: The New Era of Thinking
by: Mohammed Amrallah A., et al.
Published: (2021-05-01)

Elevated mRNA expression levels of inflammation-related genes in triple-negative breast cancer: A pilot study from North East India
by: Rizwana Sultana, et al.
Published: (2021-01-01)

Modern Immunotherapy in the Treatment of Triple-Negative Breast Cancer
by: Jakub Wesolowski, et al.
Published: (2022-08-01)

New chemotherapy options for triple-negative breast cancer (review of literature)
by: M A Sekundova, et al.
Published: (2014-03-01)

Hormonal Receptors, Human Epidermal Growth Factor Receptor-2 and Triple Negative Immunohistochemical Typing in Women with Breast Cancer in Kampala, Uganda
by: Mlole AT, et al.
Published: (2020-11-01)

Epidermal Growth Factor Receptor Expression in Triple Negative and Nontriple Negative Breast Carcinomas
by: Arathi A Changavi, et al.
Published: (2015-07-01)

Audit of delayed presentation in breast cancer from a tertiary centre in the Niger Delta, Nigeria
by: Agbonrofo PI, et al.
Published: (2020-12-01)

An unusual location for metastasis – Breast cancer in the bladder
by: Meg Hanley, et al.
Published: (2022-11-01)

Frequency of triple negative breast cancer in referrals patients to an oncology radiotherapy section
by: Maedeh Barahman, et al.
Published: (2021-01-01)

Androgen Receptor Status in Triple Negative Breast Cancer: Does It Correlate with Clinicopathological Characteristics?
by: Dubrava AL, et al.
Published: (2023-05-01)

A Holistic Approach to Hard-to-Treat Cancers: The Future of Immunotherapy for Glioblastoma, Triple Negative Breast Cancer, and Advanced Prostate Cancer
by: Carles Puig-Saenz, et al.
Published: (2023-07-01)